Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial - PubMed (original) (raw)
Clinical Trial
Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial
K Andersson et al. Contraception. 1994 Jan.
Abstract
A 20 micrograms/24 hours levonorgestrel-releasing intrauterine contraceptive device (LNG-IUD) has, in an open randomized multicenter study, been compared to the copper-releasing device Nova T during 5 years of use; 1821 women had the LNG-IUD and 937 women had the Nova T inserted. The 5-year cumulative gross pregnancy rate was 5.9% for Nova T and 0.5% for the LNG-IUD. The local effect of levonorgestrel in the uterine cavity causes reduction of menstrual blood loss and development of oligo-amenorrhea, and the termination rates because of heavy and/or prolonged menstrual flow were significantly (P < 0.001) lower among LNG-IUD users. However, the gross termination rate because of amenorrhea was 6.0 in this group. Hb increased during use of the LNG-IUD and decreased during Nova T use, and the difference between the devices was statistically significant. The incidence of pelvic inflammatory disease (PID) was low in LNG-IUD users regardless of age, whereas in the Nova T group, the PID rate was increased among the youngest women, which makes the difference between the devices significant (P < 0.01). The gross termination rate for reasons considered to be hormonal was 12.1 in the LNG-IUD group compared to 2.0 in the Nova T group (P < 0.001). The LNG-IUD is a long-acting reversible contraceptive method for 5 years with a pregnancy rate comparable to female sterilization. The incidence of PID is low even in young women. In addition, the positive health effects such as decreased menstrual blood loss and increased blood haemoglobin concentration make the LNG-IUD a favorable combination of hormonal and intrauterine contraception.
Similar articles
- Hormonal intrauterine devices.
Rybo G, Andersson K, Odlind V. Rybo G, et al. Ann Med. 1993 Apr;25(2):143-7. doi: 10.3109/07853899309164158. Ann Med. 1993. PMID: 8489751 - An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC. Chi IC. Contraception. 1991 Dec;44(6):573-88. doi: 10.1016/0010-7824(91)90078-t. Contraception. 1991. PMID: 1773615 Review. - Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Luukkainen T, Allonen H, Haukkamaa M, Holma P, Pyörälä T, Terho J, Toivonen J, Batar I, Lampe L, Andersson K, et al. Luukkainen T, et al. Contraception. 1987 Aug;36(2):169-79. doi: 10.1016/0010-7824(87)90012-6. Contraception. 1987. PMID: 3123132 Clinical Trial. - Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
Sivin I, el Mahgoub S, McCarthy T, Mishell DR Jr, Shoupe D, Alvarez F, Brache V, Jimenez E, Diaz J, Faundes A, et al. Sivin I, et al. Contraception. 1990 Oct;42(4):361-78. doi: 10.1016/0010-7824(90)90046-x. Contraception. 1990. PMID: 2124179 Clinical Trial. - Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T, Toivonen J. Luukkainen T, et al. Contraception. 1995 Nov;52(5):269-76. doi: 10.1016/0010-7824(95)00210-2. Contraception. 1995. PMID: 8585882 Review.
Cited by
- Safety profile of levonorgestrel intrauterine system: Analysis of spontaneous reports submitted to FAERS.
Chen L, Bao R, Tian X. Chen L, et al. Heliyon. 2024 Aug 28;10(17):e37112. doi: 10.1016/j.heliyon.2024.e37112. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39281579 Free PMC article. - U.S. Selected Practice Recommendations for Contraceptive Use, 2024.
Curtis KM, Nguyen AT, Tepper NK, Zapata LB, Snyder EM, Hatfield-Timajchy K, Kortsmit K, Cohen MA, Whiteman MK; Contributors. Curtis KM, et al. MMWR Recomm Rep. 2024 Aug 8;73(3):1-77. doi: 10.15585/mmwr.rr7303a1. MMWR Recomm Rep. 2024. PMID: 39106301 Free PMC article. - Premenstrual syndrome: new insights into etiology and review of treatment methods.
Modzelewski S, Oracz A, Żukow X, Iłendo K, Śledzikowka Z, Waszkiewicz N. Modzelewski S, et al. Front Psychiatry. 2024 Apr 23;15:1363875. doi: 10.3389/fpsyt.2024.1363875. eCollection 2024. Front Psychiatry. 2024. PMID: 38716118 Free PMC article. Review. - Reversible female contraceptives: historical, current, and future perspectives†.
Barton BE, Erickson JA, Allred SI, Jeffries JM, Stephens KK, Hunter MI, Woodall KA, Winuthayanon W. Barton BE, et al. Biol Reprod. 2024 Jan 13;110(1):14-32. doi: 10.1093/biolre/ioad154. Biol Reprod. 2024. PMID: 37941453 Review. - Hysteroscopic suture of levonorgestrel-releasing intrauterine system: learning curve for in vitro simulation training.
Huang J, Zhang W, Tang K, Liu X, Tian Z, Li C, Jiang S. Huang J, et al. J Int Med Res. 2023 Oct;51(10):3000605231205760. doi: 10.1177/03000605231205760. J Int Med Res. 2023. PMID: 37862790 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources